Skip to main content
This section contains press releases and other materials from third parties (including paid content). The Globe and Mail has not reviewed this content. Please see disclaimer.

Analysts Offer Insights on Healthcare Companies: Boston Scientific (BSX) and Abbott Laboratories (ABT)

Tipranks - Tue Mar 31, 9:05AM CDT

There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Boston Scientific (BSX) and Abbott Laboratories (ABT) with bullish sentiments.

End of Quarter Sale - 50% Off TipRanks

Boston Scientific (BSX)

Leerink Partners analyst Mike Kratky reiterated a Buy rating on Boston Scientific today and set a price target of $89.00. The company’s shares closed last Monday at $64.40.

According to TipRanks.com, Kratky is ranked #1529 out of 12128 analysts.

The word on The Street in general, suggests a Strong Buy analyst consensus rating for Boston Scientific with a $103.95 average price target, a 61.9% upside from current levels. In a report issued on March 18, Truist Financial also maintained a Buy rating on the stock.

See today’s best-performing stocks on TipRanks >>

Abbott Laboratories (ABT)

Bank of America Securities analyst Travis Steed maintained a Buy rating on Abbott Laboratories today. The company’s shares closed last Monday at $103.23, close to its 52-week low of $99.71.

According to TipRanks.com, Steed is a 3-star analyst with an average return of 2.4% and a 48.9% success rate. Steed covers the Healthcare sector, focusing on stocks such as Kestra Medical Technologies Ltd., GE Healthcare Technologies Inc, and Bausch + Lomb Corporation. ;'>

Currently, the analyst consensus on Abbott Laboratories is a Strong Buy with an average price target of $136.15, a 30.0% upside from current levels. In a report issued on March 24, Wells Fargo also maintained a Buy rating on the stock with a $122.00 price target.

Read More on BSX:

Disclaimer & DisclosureReport an Issue

This article contains syndicated content. We have not reviewed, approved, or endorsed the content, and may receive compensation for placement of the content on this site. For more information please view the Barchart Disclosure Policy here.